Updated:
Decheng Capital
Decheng Capital is a global life sciences investment firm based in Menlo Park, California. Founded in 2012, it invests in early-stage life science companies...
Decheng Capital
Decheng Capital is a global life sciences investment firm based in Menlo Park, California. Founded in 2012, it invests in early-stage life science companies and growth-stage healthcare companies. Decheng Capital has made 125 investments, including a Series B investment in Syneron Bio on March 31, 2026.
General information
Firm type
Generalist
Year founded
2012
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What stages does Decheng Capital target?
Records show coverage of early-stage seed, start-up, expansion, growth, and pre-IPO opportunities.
Where is Decheng Capital based?
Headquarters are in Shanghai, China.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: